These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 25400539)
1. A review of β-amyloid neuroimaging in Alzheimer's disease. Adlard PA; Tran BA; Finkelstein DI; Desmond PM; Johnston LA; Bush AI; Egan GF Front Neurosci; 2014; 8():327. PubMed ID: 25400539 [TBL] [Abstract][Full Text] [Related]
2. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Shen L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ; Alzheimers Dement; 2013 Sep; 9(5):e111-94. PubMed ID: 23932184 [TBL] [Abstract][Full Text] [Related]
3. Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer's Disease. Besson FL; La Joie R; Doeuvre L; Gaubert M; Mézenge F; Egret S; Landeau B; Barré L; Abbas A; Ibazizene M; de La Sayette V; Desgranges B; Eustache F; Chételat G J Neurosci; 2015 Jul; 35(29):10402-11. PubMed ID: 26203136 [TBL] [Abstract][Full Text] [Related]
4. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ; Alzheimers Dement; 2012 Feb; 8(1 Suppl):S1-68. PubMed ID: 22047634 [TBL] [Abstract][Full Text] [Related]
5. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative. Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ; Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505 [TBL] [Abstract][Full Text] [Related]
6. Biomarkers and phenotypic expression in Alzheimer's disease: exploring the contribution of frailty in the Alzheimer's Disease Neuroimaging Initiative. Canevelli M; Arisi I; Bacigalupo I; Arighi A; Galimberti D; Vanacore N; D'Onofrio M; Cesari M; Bruno G; Geroscience; 2021 Apr; 43(2):1039-1051. PubMed ID: 33210215 [TBL] [Abstract][Full Text] [Related]
7. Development of Alzheimer-disease neuroimaging-biomarkers using mouse models with amyloid-precursor protein-transgene expression. Teipel SJ; Buchert R; Thome J; Hampel H; Pahnke J Prog Neurobiol; 2011 Dec; 95(4):547-56. PubMed ID: 21601614 [TBL] [Abstract][Full Text] [Related]
8. Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers. Chételat G; Fouquet M Rev Neurol (Paris); 2013 Oct; 169(10):729-36. PubMed ID: 24016463 [TBL] [Abstract][Full Text] [Related]
9. Imaging Techniques in Alzheimer's Disease: A Review of Applications in Early Diagnosis and Longitudinal Monitoring. van Oostveen WM; de Lange ECM Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672696 [TBL] [Abstract][Full Text] [Related]
10. Alzheimer's Dementia: The Emerging Role of Positron Emission Tomography. Tripathi SM; Murray AD Neuroscientist; 2022 Oct; 28(5):507-519. PubMed ID: 33660556 [TBL] [Abstract][Full Text] [Related]
11. A literature review of MRI techniques used to detect amyloid-beta plaques in Alzheimer's disease patients. Yu B; Shan Y; Ding J Ann Palliat Med; 2021 Sep; 10(9):10062-10074. PubMed ID: 34551578 [TBL] [Abstract][Full Text] [Related]
13. Current neuroimaging techniques in Alzheimer's disease and applications in animal models. Zhang L; Chang RC; Chu LW; Mak HK Am J Nucl Med Mol Imaging; 2012; 2(3):386-404. PubMed ID: 23133824 [TBL] [Abstract][Full Text] [Related]
14. Alzheimer's Disease Cerebrospinal Fluid and Neuroimaging Biomarkers: Diagnostic Accuracy and Relationship to Drug Efficacy. Khan TK; Alkon DL J Alzheimers Dis; 2015; 46(4):817-36. PubMed ID: 26402622 [TBL] [Abstract][Full Text] [Related]
15. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R; Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606 [TBL] [Abstract][Full Text] [Related]
16. Application of the IWG-2 Diagnostic Criteria for Alzheimer's Disease to the ADNI. Wang HF; Tan L; Cao L; Zhu XC; Jiang T; Tan MS; Liu Y; Wang C; Tsai RM; Jia JP; Yu JT; J Alzheimers Dis; 2016; 51(1):227-36. PubMed ID: 26836176 [TBL] [Abstract][Full Text] [Related]
17. Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome. Neale N; Padilla C; Fonseca LM; Holland T; Zaman S Neuroimage Clin; 2018; 17():263-271. PubMed ID: 29159043 [TBL] [Abstract][Full Text] [Related]
18. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review. Ruan Q; D'Onofrio G; Sancarlo D; Bao Z; Greco A; Yu Z BMC Geriatr; 2016 May; 16():104. PubMed ID: 27184250 [TBL] [Abstract][Full Text] [Related]